Option Care Health Reports Q2 2026 Results: Modest Growth and Strategic Execution
Key Highlights for Investors
- Net Revenue: \$1.44 billion in Q2 2026, an increase of 1.9% year-over-year.
- GAAP Net Income: \$53.9 million, a 6.7% rise year-over-year.
- GAAP Diluted Earnings Per Share (EPS): \$0.35, up 12.9% from Q2 2025.
- Adjusted EBITDA: \$117.5 million, up 3.0%.
- Adjusted Diluted EPS: \$0.45, up 9.8%.
- Cash Provided by Operating Activities: \$184 million in Q2 2026.
- Share Repurchases: \$150 million of outstanding shares repurchased in Q2 2026.
CEO Statement and Operational Overview
John C. Rademacher, Chief Executive Officer, commented on the solid second quarter performance, attributing the results to strong operational execution and the positive impact of the company’s 2026 strategic initiatives. He emphasized continued confidence in Option Care Health’s underlying fundamentals and highlighted ongoing efforts to position the company for sustainable long-term growth. Rademacher pointed to the company’s robust clinical platform, significant market opportunities, and operational discipline as key drivers for achieving 2026 priorities and creating meaningful value for patients, partners, and shareholders.
Updated Financial Guidance: Full Year 2026 & Q3 2026
Full Year 2026 Guidance
- Net Revenue: Projected between \$5.675 billion and \$5.775 billion.
- Adjusted Diluted EPS: Expected to be \$1.85 to \$1.92.
- Adjusted EBITDA: Guidance range of \$480 million to \$495 million.
- Cash from Operating Activities: At least \$320 million forecast for FY26.
Q3 2026 Guidance
- Sequential Net Revenue Growth: Low to mid single-digit percentage increase compared to Q2 2026.
- Sequential Adjusted EBITDA Growth: Mid single-digit percentage increase expected.
Price Sensitive: The updated guidance reflects confidence in continued growth, which could be a key driver for share value, especially if the company meets or exceeds these targets.
Shareholder-Focused Events and Capital Allocation
- Share Repurchases: The company repurchased \$150 million of its outstanding shares in Q2 2026, a move that is typically supportive of share price by reducing share count and signaling management’s confidence in Option Care Health’s valuation.
- Cash Position: As of June 30, 2026, the company reported \$193.8 million in cash and cash equivalents.
- Balance Sheet Strength: Total assets were \$3.38 billion, with total liabilities at \$2.12 billion and stockholders’ equity at \$1.26 billion.
- Debt: Long-term debt, net of discount and current portion, stood at \$1.15 billion, indicating a significant but manageable leverage position.
Detailed Financial Performance
- Gross Profit: \$267.3 million for Q2 2026, with a gross margin improvement.
- Operating Income: \$85.1 million for Q2 2026, up from \$82.7 million in the prior year.
- Operating Expenses: Total operating costs and expenses were \$182.1 million in Q2 2026.
- Interest Expense: \$14.0 million in Q2 2026, slightly lower than the prior year.
- Net Cash From Operations: \$171.5 million for the first half of 2026, more than double the \$83.1 million generated in the same period of 2025, highlighting strong cash flow growth.
- Share Count Reduction: Weighted average diluted shares outstanding dropped from 164.1 million in Q2 2025 to 153.5 million in Q2 2026, reflecting the effect of share repurchases.
Non-GAAP Measures and Reconciliation
Option Care Health continues to report Adjusted Net Income, Adjusted EBITDA, and Adjusted Diluted EPS as key non-GAAP metrics. These adjustments exclude items such as intangible asset amortization, stock-based compensation, losses on extinguishment of debt, and restructuring, acquisition, and integration expenses. Management believes these measures provide a clearer picture of core operating performance and facilitate better comparison with historical results and industry peers.
Note: The company does not provide forward reconciliations for these metrics due to the uncertainty and variability of certain reconciling items.
Forward-Looking Statements and Risks
The company’s outlook includes forward-looking statements subject to risks such as changes in laws or regulations, loss of payer relationships, industry shifts, and potential litigation. Investors are cautioned that actual results could vary materially, and are encouraged to review risk factors disclosed in Option Care Health’s SEC filings.
Conference Call Details
Option Care Health will host a conference call to discuss these results on Wednesday, July 29, 2026, at 8:30 a.m. ET. Interested shareholders can access the live audio webcast at investors.optioncarehealth.com. A replay will be available for 90 days.
About Option Care Health
Option Care Health is the nation’s largest independent provider of home and alternate site infusion services, employing over 8,000 team members, including more than 5,000 clinicians, and serving all 50 states. The company aims to elevate care standards for patients with acute and chronic conditions and continues to expand its leadership and national scale in the infusion care market.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. All forward-looking statements are subject to risks and uncertainties. Investors should review official filings and consult with their financial advisors before making investment decisions.
